TISSUE DIAGNOSTIC MARKET ANALYSIS

Name: Tissue Diagnostic Market News
Creator: Coherent Market Insights
License: https://www.coherentmarketinsights.com/privacy-policy

Tissue Diagnostic Market By Product Type (Instruments, Consumables), By Technology (In Situ Hybridization, Digital Pathology, Immunohistochemistry), By Disease (Breast Cancer, Lymphoma Cancer, Gastric Cancer), By End User (Research Laboratories, Hospitals, Contract Research Organizations) – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

Key Developments in Tissue Diagnostic Market

In May 2019, Roche launched VENTANA ROS1 (SP384) Rabbit Monoclonal Primary Antibody, an in vitro diagnostic ROS1 immunohistochemistry (IHC) assay. This assay detects the presence of ROS1 protein in tissue, and may be useful in identifying ROS1-positive cancer cases.
In August 2019, Lunaphore Technologies SA launched LabSat, a device to perform immunohistochemistry (IHC) tests for detecting specific cancer biomarkers in tissue samples from cancer patients.
In July 2018, Aquaro Histology launched Aquaro Wishbone microtome blade-handling tool. The device is used to remove and dispose of blades, as well as insert and align them without touching them.
In March 2017, Sakura Finetek USA, Inc. launched first and only Cryostat including Tissue-Tek Cryo3 Flex Cryostat Mohs. The new cryostat system is used to decrease the time to get complete sections, and in parallel to preserve valuable tissues.